- ongoing, recruitingTherapeutic exploratory (Phase II)
Open-label, Multi-centre, Non-Inferiority study of safety and immunogenicity of BIMERVAX as heterologous booster for the prevention of coronavirus disease 2019 (COVID-19) in adolescents from 12 years to less than 18 years of age.
This study is looking at a new COVID-19 booster vaccine called BIMERVAX for teenagers aged 12 to 17. It aims to see if BIMERVAX is as safe and effective as another vaccine, HIPRA-HH-2, in boosting protection against the Omicron variant of COVID-19.
Spain - recruiting
COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics
This study looks at whether we can use a phone app to spot early signs of COVID-19 getting worse. It uses your voice and breathing sounds to predict if someone might need intensive care, helping hospitals prepare.
France - recruitingNA
Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19
This study looks at how "smell training" can help people whose sense of smell changed after COVID-19. We're comparing two different sets of smells to see which works best to bring back normal smelling.
Canada - active not recruitingPHASE1
COVID-19 Omicron BA.5 Subvariant Dose Finding Infection Study
Researchers are studying how much of the Omicron BA.5 virus causes infection in people who've had COVID-19 vaccines or infections before. This helps them understand the virus better and test treatments more safely, helping to protect people from getting very sick from future COVID-19 variants.
United Kingdom - active not recruitingPHASE2, PHASE3
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
This study is testing a new COVID-19 vaccine to see how well it works and if it's safe. It's for adults aged 18 and over and involves injections and monitoring over time.
United States · Argentina · Brazil - ongoing, recruitingTherapeutic use (Phase IV)
TURN-COVID Biobank: The Dutch cohort study tor the evaluation of the use of neutralizing monoclonal antibodies and other antiviral agents against SARS-CoV-2
This study looks at how well certain COVID-19 treatments work, such as Ronapreve, Evusheld, Xevudy, and Paxlovid. It’s also building a collection of samples to help understand these treatments and new ones in the future. The study is for adults with COVID-19.
Netherlands